Effects ofCYP3A5genotypes,ABCB1 C3435TandG2677T/Apolymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients

Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation

(2013) V. Guy-Viterbo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients

(2013) Xiao-cong Zuo et al.   Pharmacogenetics and Genomics

Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients

(2012) Nayoung Han et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction

(2012) Itziar Oteo et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Combinational Effect of Intestinal and Hepatic CYP3A5 Genotypes on Tacrolimus Pharmacokinetics in Recipients of Living Donor Liver Transplantation

(2012) Eunhee Ji et al.   TRANSPLANTATION

Impact of Cytochrome P450 3A and ATP-Binding Cassette Subfamily B Member 1 Polymorphisms on Tacrolimus Dose-Adjusted Trough Concentrations Among Korean Renal Transplant Recipients

(2012) J.-H. Cho et al.   TRANSPLANTATION PROCEEDINGS

Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in Healthy Chinese Volunteers

(2011) Ling Xue et al.   PHARMACOLOGY

Point: A Call for Advanced Pharmacokinetic and Pharmacodynamic Monitoring to Guide Calcineurin Inhibitor Dosing in Renal Transplant Recipients

(2010) H. H. van Rossum et al.   CLINICAL CHEMISTRY

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

(2010) Christine E. Staatz et al.   CLINICAL PHARMACOKINETICS

Association of ABCB1, CYP3A4*18B and CYP3A5*3 genotypes with the pharmacokinetics of tacrolimus in healthy Chinese subjects: a population pharmacokinetic analysis

(2010) X.-J. Shi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Use of Pharmacogenetics to Optimize Immunosuppressive Therapy

(2010) Iain A M MacPhee   THERAPEUTIC DRUG MONITORING

CYP3A5 *1 Allele: Impacts on Early Acute Rejection and Graft Function in Tacrolimus-Based Renal Transplant Recipients

(2010) Sang-Il Min et al.   TRANSPLANTATION

CYP3A5*1/*3 genotype influences the blood concentration of tacrolimus in response to metabolic inhibition by ketoconazole

(2009) Nirupama Chandel et al.   Pharmacogenetics and Genomics

A Fast Ultra-Performance Liquid Chromatography Method for Simultaneous Quantification of Mycophenolic Acid and Its Phenol- and Acyl-Glucuronides in Human Plasma

(2009) Flora Tshinanu Musuamba et al.   THERAPEUTIC DRUG MONITORING

Opportunities to Optimize Tacrolimus Therapy in Solid Organ Transplantation: Report of the European Consensus Conference

(2009) Pierre Wallemacq et al.   THERAPEUTIC DRUG MONITORING

Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients

(2008) Masahide Fukudo et al.   Pharmacogenetics and Genomics